MERRIMACK PHARMACEUTICALS INC Proceeds from Convertible Debt
MERRIMACK PHARMACEUTICALS INC reported Proceeds from Convertible Debt of $1.19 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-12-15
- MERRIMACK PHARMACEUTICALS INC proceeds from convertible debt for the quarter ending 2016-09-30 was $160.00K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2016-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.19M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $1.02M 10-Q · filed 2017-08-09 | |||
| 2014-12-31 | $1.04M 8-K · filed 2017-12-15 | |||
| 2013-09-30 | $120.62M 10-Q · filed 2013-11-08 |